Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma.
about
Molecular pathological epidemiology of epigenetics: emerging integrative science to analyze environment, host, and diseaseAberrant promoter methylation of PPP1R3C and EFHD1 in plasma of colorectal cancer patientsMethylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.Review of the development of DNA methylation as a marker of response to neoadjuvant therapy and outcomes in rectal cancer.Genome-wide DNA methylation profiling reveals cancer-associated changes within early colonic neoplasia.Genetic and epigenetic aberrations occurring in colorectal tumors associated with serrated pathwayClinicopathological and molecular alterations in early gastric cancers with the microsatellite instability-high phenotype.Epigenetic silencing of NTSR1 is associated with lateral and noninvasive growth of colorectal tumors.A prospective study of duration of smoking cessation and colorectal cancer risk by epigenetics-related tumor classificationTP53 mutation at early stage of colorectal cancer progression from two types of laterally spreading tumorsSEPT9 and SHOX2 DNA methylation status and its utility in the diagnosis of colonic adenomas and colorectal adenocarcinomas.Storkhead box 2 and melanoma inhibitory activity promote oral squamous cell carcinoma progression.Aberrantly methylated genes in human papillary thyroid cancer and their association with BRAF/RAS mutation.Molecular differences in the microsatellite stable phenotype between left-sided and right-sided colorectal cancer.Accumulation of aberrant DNA methylation during colorectal cancer development.Two subtypes of colorectal tumor with distinct molecular features in familial adenomatous polyposis.Molecular subtypes of colorectal cancers determined by PCR-based analysis.DNA methylation accumulation and its predetermination of future cancer phenotypes.Analysis of molecular alterations in laterally spreading tumors of the colorectum.Genetic differences stratified by PCR-based microsatellite analysis in gastric intramucosal neoplasia.A pre-neoplastic epigenetic field defect in HCV-infected liver at transcription factor binding sites and polycomb targets.Epigenetic and genetic dispositions of ovarian carcinomasMolecular alterations in colorectal adenomas and intramucosal adenocarcinomas defined by high-density single-nucleotide polymorphism arrays.Molecular profiling and genome-wide analysis based on somatic copy number alterations in advanced colorectal cancers.Cancer-type OATP1B3 mRNA has the potential to become a detection and prognostic biomarker for human colorectal cancer.Methylation epigenotypes and genetic features in colorectal laterally spreading tumors.Comprehensive molecular analysis based on somatic copy number alterations in intramucosal colorectal neoplasias and early invasive colorectal cancers.
P2860
Q24289344-0CACDA87-A5F0-45D7-BB1A-932BEEA579E3Q34998496-9F6295FE-0D4C-47B6-B65C-39CA4A8C2668Q35052681-E306C2AD-9A07-434B-B0C9-A33CE0AB58EFQ35879988-9C19F4DA-3116-4DE2-BBE2-E66E2EF19B43Q36359503-45BE97A8-158B-4A45-AA53-3D6A0E491CF0Q36533260-4D483FB2-28E9-4FB5-852A-477403AA7B85Q36536744-81724E92-9F2F-4D6B-8385-3C38367AFA48Q36557481-A130374B-480D-4DED-9714-4D5AABCA1A0FQ36974863-CC8B4081-0075-4950-9554-D6D403851EFCQ37142410-E4E601E9-C35D-4A2A-945D-7DAE45B41BB0Q37267725-AC4A8568-CDF2-44B5-8DF6-33DF8C014C82Q37295783-F62B334A-8A8A-4961-A20B-F99995922220Q37365523-E22082EB-BDCC-47FC-890B-DFBCF064D464Q37394567-15BC1406-454E-4929-A646-3FE30E01C45DQ37578731-1D0D2EED-8C3E-43EF-A380-EFFCCFDA6BEDQ37708920-36517EDB-8BD0-4B5E-BCBB-8BBDCCA2A56DQ37735649-D19ABF8B-D04F-4CCD-BBA3-30AD1D9602ADQ38223048-0D3C6E60-67F9-4031-A2F6-CBD2F30D3A04Q39322003-1832A340-B466-4ACA-B963-6EA1B6E0B1C9Q39728452-EF65689A-A598-4115-A11F-8E69F066ED83Q40512450-D032E188-4B21-4332-9106-0D43DC4F9A9FQ42112898-8AAE4C61-40CB-46C5-A3D2-88E98E785B97Q47134444-A352D33A-ACD5-4D5F-82FC-CDE57458EC2AQ48136191-C7EAB42E-3A05-4907-9D46-EABB4AA9EB2AQ50596135-689B4136-EFDC-4FF5-B1E5-6AE182F87A4CQ54220105-465D2C80-3CAD-474A-A366-ED9D471C3489Q54982360-C5DAE97B-E821-42FA-9819-1712D4AB6F01
P2860
Intermediate methylation epigenotype and its correlation to KRAS mutation in conventional colorectal adenoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Intermediate methylation epige ...... nventional colorectal adenoma.
@ast
Intermediate methylation epige ...... nventional colorectal adenoma.
@en
Intermediate methylation epige ...... nventional colorectal adenoma.
@nl
type
label
Intermediate methylation epige ...... nventional colorectal adenoma.
@ast
Intermediate methylation epige ...... nventional colorectal adenoma.
@en
Intermediate methylation epige ...... nventional colorectal adenoma.
@nl
prefLabel
Intermediate methylation epige ...... nventional colorectal adenoma.
@ast
Intermediate methylation epige ...... nventional colorectal adenoma.
@en
Intermediate methylation epige ...... nventional colorectal adenoma.
@nl
P2093
P1476
Intermediate methylation epige ...... nventional colorectal adenoma.
@en
P2093
Atsushi Kaneda
Atsushi Nakajima
Hirokazu Takahashi
Hiroyuki Aburatani
Keisuke Matsusaka
Kiwamu Akagi
Koichi Yagi
Yasuyuki Seto
P304
P356
10.1016/J.AJPATH.2011.10.010
P407
P577
2011-11-21T00:00:00Z